Asia Pac. PubMed Google Scholar. Wu, Y. Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice. Article ADS CAS PubMed PubMed Central Google Scholar.

Han, S. Effect of retinoic acid in experimental diabetic nephropathy. Cell Biol. Tamaki, M. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element. Trasino, S.

Amelioration of diabetic nephropathy using a retinoic acid receptor β2 agonist. Centers for Disease Control and Prevention.

The National Health and Nutritional Examination Survey NHANES Analytic and Reporting Guidelines. Atlanta, CDC, Kang, H. Exposure to phthalates and environmental phenols in association with chronic kidney disease CKD among the general US population participating in multi-cycle NHANES — Total Environ.

Article ADS CAS PubMed Google Scholar. Atlanta, Centers for Disease Control and Prevention, April Cooper, M. A promising outlook for diabetic kidney disease. Pedrini, M. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis.

Frey, S. Vitamin A metabolism and adipose tissue biology. Nutrients 3 1 , 27—39 Blaner, W. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders.

Shah, M. Comparison of nutrient intakes in South Asians with type 2 diabetes mellitus and controls living in the United States. Diabetes Res. Basualdo, C. Vitamin A retinol status of first nation adults with non-insulin-dependent diabetes mellitus.

Khayyatzadeh, S. Nutrient patterns and their relationship to metabolic syndrome in Iranian adults. Su, L. Dietary total Vitamin A, β-carotene, and retinol intake and the risk of diabetes in Chinese adults with plant-based diets.

Chittka, D. Long-term expression of glomerular genes in diabetic nephropathy. Renal Assoc. CAS Google Scholar. Sierra-Mondragon, E. Marie, A. Parkinsons Dis. Kim, S. Retinol suppresses the activation of Toll-like receptors in MyD and STAT1-independent manners. Inflammation 36 2 , — Jha, J.

Diabetes and kidney disease: Role of oxidative stress. Redox Signal. Rayego-Mateos, S. Targeting inflammation to treat diabetic kidney disease: the road to Kidney Int.

Download references. The Science and technology fund of Chengdu Medical College CYZYB Chengdu Jinniu District Medical Association JNQN Beijing Medical Health Foundation Medical Research Fund KJB Sichuan Provincial Association of Medical Sciences Fund TG Department of Nephrology, The First Affiliated Hospital of Chengdu Medical College, No.

The Second Affiliated Hospital of Chengdu Medical College, Chengdu, , China. You can also search for this author in PubMed Google Scholar. Conception and design of the study: R. Acquisition and analysis of data: R. Correspondence to Shaoqing Wang or Xiang Xiao.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.

If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. Reprints and permissions. Ma, R. Retinol intake is associated with the risk of chronic kidney disease in individuals with type 2 diabetes mellitus: results from NHANES.

Sci Rep 13 , Download citation. Received : 21 April Accepted : 11 July Published : 18 July Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. By submitting a comment you agree to abide by our Terms and Community Guidelines.

If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Skip to main content Thank you for visiting nature. nature scientific reports articles article. Download PDF. Subjects Diseases Endocrinology Nephrology. Abstract The aim of this study was to investigate the potential association between retinol intake and the risk of chronic kidney disease CKD in individuals with type 2 diabetes mellitus T2DM.

Materials and methods Study design and individuals The National Health and Nutrition Examination Survey NHANES is an ongoing study that provides valuable health-related data on adults and children in the United States.

Figure 1. Flowchart of included individuals in this study. Full size image. Results Baseline characteristics The data of 49, individuals registered in the NHANES database from to were included. Table 1 Baseline clinical features of enrolled T2DM patients with and without CKD. Full size table.

Table 2 Baseline clinical features of enrolled T2DM patients with different retinol intake. Table 3 Relationship between retinol intake and clinical indicators. Figure 2. Figure 3. Discussion This study is the first to investigate the association between retinol intake and the risk of CKD in individuals with T2DM in humans.

References Center for Disease Control and Prevention. Article CAS PubMed Google Scholar Burrows, N. Article PubMed PubMed Central Google Scholar International Diabetes Federation.

Article PubMed Google Scholar Ko, G. Article PubMed PubMed Central Google Scholar Kramer, H. Article PubMed Google Scholar Du, C. Article CAS PubMed Google Scholar Bar-El Dadon, S. Article CAS PubMed Google Scholar Yadav, A.

Our findings identify significant associations between the xanthophyll carotenoids and eGFR. Further investigations are required to confirm these findings. Renal dysfunction remains a significant public health concern given its potential to progress to chronic kidney disease CKD and end-stage renal disease ESRD without intervention.

Progressive renal dysfunction is identified typically through repeated measures of serum creatinine and estimated glomerular filtration rate eGFR.

CKD is categorised into five stages based on eGFR range. CKD is also associated with higher risk of cardiovascular events, hospitalisation and premature death 4.

As end-organs, the kidneys and brain have comparable anatomic and haemodynamic characteristics which leave them susceptible to common pathogenic mechanisms 7. As such, CKD and AD share similar risk factor profiles comprising hypertension, diabetes mellitus and hypercholesterolaemia, with similar prevalence of small-vessel disease 8.

Furthermore, variation within apoE, a protein crucial to lipoprotein metabolism, including reverse cholesterol transport, hepatic clearance of chylomicrons and very low-density lipoprotein remnants, has been reported in association with chronic kidney disease progression, independent of other risk factors 9.

In addition, apoE4 has been consistently shown to exhibit poorer antioxidant properties in comparison to apoE3 and apoE2 Multiple pathways may contribute to the close association between renal dysfunction and cognitive impairment including shared mechanisms resulting in vascular pathophysiology Depression, neurological sequelae and cognitive impairment are also severe co-morbidities of CKD that significantly reduce quality of life In recent years, non-traditional risk factors such as inflammation and oxidative stress OS have been implicated in the pathogenesis of both CKD and cognitive decline While the precise mechanisms remain unclear, there is substantial evidence that AD is associated with OS and altered serum dietary antioxidant status 14 , Whether these changes are secondary to diminished antioxidant intake or the excessive generation of reactive oxygen species remains uncertain.

However, an association between OS and eGFR has been established and the detrimental consequences of OS in CKD have been associated with increased mortality in patients 17 , Importantly, malnourished individuals with poor renal function exhibit increased evidence of OS compared to those receiving adequate nutrition, highlighting the importance of dietary antioxidants in those with poor renal function However, the majority of studies investigating OS and antioxidant defences in renal disease have focused largely on ESRD and endogenous markers of OS The aim of this study was to investigate the association between serum antioxidant status and renal function, as measured by eGFR, while controlling for AD status.

Given advanced CKD stages 4 and particularly stage 5 could impact on dietary antioxidant levels secondary to reduced dietary intake or increased losses from dialysis therapies , we sought to recruit older adults who were known not to be suffering from advanced chronic kidney disease and were not attending nephrology clinics to avoid confounding from late CKD stages.

We examined serum concentrations of nine dietary antioxidants including three antioxidant vitamins retinol, α-tocopherol, γ-tocopherol and six carotenoids α-carotene, β-carotene, β-cryptoxanthin, lutein, lycopene and zeaxanthin.

A cross-sectional study of participants was conducted to assess the association between eGFR and serum antioxidant status. Recruitment and testing of all participants was undertaken between August and by one investigator M. and has been described elsewhere The population consisted of prevalent AD cases and unmatched cognitively intact individuals.

Participants with AD were identified and recruited from memory clinics in Belfast City Hospital, UK and Knockbracken Healthcare Park, UK, or from records of previous attendance at the same clinics. Individuals were excluded if they had a diagnosis of dementia not attributable to AD.

Various recruitment strategies were used to identify cognitively intact participants. These strategies included asking carers of patients attending any outpatient clinic in the study hospital to participate.

A university press-release resulted in the recruitment of further volunteers. All participants provided written informed consent prior to study entry, which adhered to the principles of the Declaration of Helsinki.

Clinical governance and ethical approval was obtained prior to study commencement and the research was undertaken in accordance with relevant guidelines under ethical approval by the Office for Research Ethics Committees Northern Ireland. Upon enrolment, all participants underwent an examination that included blood pressure measurement and provision of a blood sample.

Standard venepuncture was used to draw blood and determine serum creatinine for eGFR using the CKD-EPI equation Serum levels of nine dietary antioxidants retinol, α-tocopherol, γ-tocopherol, α-carotene, β-carotene, β-cryptoxanthin, lutein, lycopene and zeaxanthin were determined by high performance liquid chromatography HPLC with diode array detection Internal quality control samples were incorporated into every run and validation was conducted against National Institute of Standards and Technology standard reference material.

Participants were further assessed through the completion of questionnaires via interviews with themselves or their carer when appropriate. Use of medication and co-morbidities were noted as present or absent following determination by self-report or consultation of medical notes.

Smoking history was calculated as a cumulative dose in pack years. All statistical analyses were conducted using SPSS statistics version 23 IBM Corp. Armonk, NY. Summary statistics were presented as mean standard deviation for continuous data, all of which was normally distributed, and relative frequencies percentage by group, for categorical variables.

These were presented for all participants and separately for the cognitively intact sub-group. The variation in eGFR associated with a unit increase in concentration of each of the nine dietary antioxidants examined was determined. These coefficients were calculated before and after adjustment for confounders.

The final model was determined using a backward selection procedure that retained only variables which showed a significant association with eGFR. Thus, the final model used to calculate the regression coefficients contained age years , gender and smoking status. AD was also retained due to the composition of the study population.

A sensitivity analysis was performed to investigate any potential confounding effects of AD status in the relationship between eGFR and serum antioxidant status. In a sensitivity analysis, multiple linear regression was performed in cognitively intact individuals only, with eGFR as the dependent variable and serum concentrations of the dietary antioxidants individually entered as independent variables along with age years , gender and smoking status.

The mean age and standard deviation SD of the study population was The mean SD eGFR across the population was Both vitamin E isoforms and the remaining carotenoids demonstrated no significant association with eGFR in univariate analyses.

The remaining antioxidants were not significant in the multivariate analyses. Although the direction of effect was maintained, no significant associations were detected in participants with no copies of APOE4 Table 3. The sensitivity analysis was performed in cognitively intact participants only Table 5.

This analysis was similarly adjusted for age years , gender, number of APOE4 alleles and smoking status. There were no significant associations between eGFR and vitamin E or the remaining carotenoids. This large cross-sectional analysis examined the relationship between serum levels of nine dietary antioxidants and renal function recording significant associations between the xanthophyll serum carotenoid lutein and eGFR.

A significant negative association was also detected between eGFR and serum retinol although this was not significant in the sensitivity analysis conducted on cognitively intact participants only. Our results support the findings reported from interventional trials of exogenous antioxidants in renal dysfunction with no association detected between vitamin E and renal function Given our observations, the potential interventional benefits of the significantly associated serum xanthophyll carotenoids with renal function, especially in those carrying the APOE4 allele, warrants further investigation.

Several potential limitations of our study should be considered. Firstly, study participants were recruited as part of a case-control study initially comparing AD to cognitively intact participants However, the potential confounding of AD status was minimised through adjustment in our analyses in addition to the separate sensitivity analysis undertaken that included cognitively intact participants only.

No independent association between eGFR and AD status was detected in this study population Despite observations of similar effect sizes in both the sensitivity analysis of cognitively intact individuals and the full analysis, the loss of a significant association between eGFR and retinol in the sensitivity analysis only, may result from a smaller sample size given the reduced power to detect association.

Secondly, convenience sampling methods were used to recruit participants. While this enabled recruitment of a large sample size, it may have led to sampling bias in participant selection.

It may also partially explain the lower mean and narrower range of eGFR measurements than would normally be expected in a similar population-based study of elderly participants Future studies should ideally investigate a broader population with a higher mean and wider range of eGFR values.

Thirdly, the use of a single measure of eGFR derived from a serum creatinine-based equation may limit the strength of assumptions made from the data. Ideally, serial measurements should be used and other studies have utilised cystatin-C which may offer a more precise estimate of renal function in an elderly population with a high prevalence of co-morbidities 2.

Finally, it is possible that other factors that influence eGFR or antioxidant status were not sufficiently considered within our data. A potentially important omission may be information on participant dietary intake and supplement use, which could have been recorded through food diaries or other questionnaire-based methods.

However, the value of these methods to examine the relationship between diet and disease risk may have been limited by the potential recall bias of some of the study participants, should it have been used. The cross-sectional nature of our study precludes assumptions about the temporal relationship of any associations observed between eGFR and serum antioxidant status.

Therefore, dietary information may have been useful in determining whether altered levels of serum antioxidants are truly a result of declining renal function or reduced dietary consumption.

Our investigation of a non-CKD population is likely to have removed the confounding effects of any dietary restrictions. While an established association between AD and poor dietary intake has been demonstrated previously, the sensitivity analysis undertaken is also likely to have mitigated its effects As such, the strength of our conclusions may be limited without a valid measure of dietary intake and supplement use.

Furthermore, Viggiano and colleagues recently suggested individuals with MCI and CKD may represent a distinct or extreme phenotype in comparison to those with MCI and no renal impairment in the general population The association between MCI and CKD is most evident in individuals with late CKD stages 4 and 5 and in persons receiving chronic dialysis treatment Our study also had several strengths including the large sample size and the well characterised study population enabling appropriate adjustment for confounding effects.

Importantly, the use of HPLC to determine serum levels of antioxidants is an objective measurement that provides a reliable evaluation of the relationship between dietary constituents and disease markers, including eGFR Separate analyses were also undertaken to evaluate associations between eGFR and antioxidant measures according to APOE status which identified additional associations between eGFR and zeaxanthin and β-carotene in individuals with at least one APOE4 allele.

The apoE4 variant has consistently shown poorer antioxidant properties in comparison to apoE3 and apoE2 Geographic variation in APOE allele frequencies and all-cause mortality has been reported previously and may account for some of the variation in the associations identified between studies Improved understanding of the genetic architecture that underpins antioxidant bioavailability and bioactivity will enable personalised and more effective recommendations for antioxidant intake through dietary intervention or nutritional supplementation Multiple abnormalities of redox status have been reported in patients with progressive renal dysfunction Many of these studies have shown a gradual elevation of oxidative damage and a reduction in endogenous antioxidant defences as disease progresses However, despite the biological plausibility of potential benefit, other dietary antioxidants have been inadequately investigated with regard to renal dysfunction and studies have been limited by low sample size and inconsistent findings Retinol is one of several compounds which comprise vitamin A and is physiologically held within strict parameters due to its important role in cell metabolism It is commonly found in food sources such as liver, fish and eggs.

Our findings demonstrate a significant inverse association between serum levels of retinol and eGFR which is consistent with previous findings 38 , Furthermore, patients with high retinol levels have been shown to have a greater risk of developing CKD compared to those with lower levels Our findings support evidence that raised serum retinol levels may represent a biomarker of CKD risk.

However, the temporal relationship of this association remains uncertain and the reduced significance of retinol in our sensitivity analysis of cognitively intact individuals only raises the potential confounding influence of AD status on the association observed.

Carotenoids are lipophilic phytochemicals which can be divided into two sub-classes according to their polarity: non-polar carotenes including α-carotene, β-carotene and lycopene and polar xanthophylls including lutein, zeaxanthin and β-cryptoxanthin Each carotenoid exhibits individual antioxidant properties depending on its unique functional group and magnitude of conjugated double-bonds.

Our findings support the limited evidence available for the carotene subclass insofar as α-carotene and β-carotene show no significant association with eGFR 39 , This may be due to their status as pro-vitamin A molecules that are guided by a negative feedback from high retinol levels in renal disease reducing their conversion to retinol Our findings may indicate that the relationship of α-carotene and β-carotene to retinol balances their oxidant-scavenging effects and produces unaltered levels overall in reduced kidney function.

Interestingly, our study also found no significant association between serum levels of lycopene and eGFR. Lycopene has an unsaturated chemical structure that provides a powerful ability to quench free radicals in vitro and is the predominant carotenoid in human serum Low circulating lycopene levels have furthermore been linked with ESRD, although these findings may have been influenced by the complicated effects of haemodialysis describe as a common discrepancy between in vitro antioxidant studies and findings in human subjects, highlighting the necessity for improved understanding of the mechanisms that influence antioxidant defences and renal function Evaluation of the xanthophyll subclass and renal function has been limited.

The lutein isomer investigated in this study was significantly associated with eGFR in all our analyses and highlights the importance of the need for further research into the role of xanthophylls and their influence on renal function, which is poorly understood.

Vitamin E is a principal dietary antioxidant with powerful in vitro free radical quenching properties. The term vitamin E refers to a group of eight isoforms consisting of four tocopherols and four tocotrienols which are prevalent in vegetable oils, nuts and seeds in varying proportions Our study found no significant association between eGFR and either α-tocopherol or γ-tocopherol, supporting the findings of several observational studies that examined plasma levels of vitamin E predominantly α-tocopherol in pre-dialysis CKD patients 39 , Similar findings have been reported in haemodialysis patients when blood samples were taken prior to the commencement of treatment In contrast, other studies have reported reduced levels of vitamin E in CKD patients when compared to healthy controls Nevertheless, the potential clinical benefit of antioxidant therapy in improving renal function in pre-dialysis CKD patients following the administration of intravenous antioxidants including iron has been reported A recent systematic review also indicated that antioxidant agents significantly decreased albuminuria in diabetic kidney disease DKD patients, despite significant limitations of small study size and heterogeneity The limited number of interventional studies of dietary antioxidants in CKD have been largely focused on vitamin E isoforms mainly alpha-tocopherol and late stages of disease with little success.

Ramos et al. found no changes in OS biomarkers in pre-dialysis CKD patients receiving mixed tocopherols and lipoic acid In haemodialysis patients, exogenous antioxidant trials have had similarly poor outcomes The failure of these trials may be particularly important, as haemodialysis has been shown to exacerbate oxidative stress and the diminution of antioxidant defences although the benefits of tocopherol supplementation remains unproven Interestingly, a recent clinical trial reported the beneficial effects of supplementation with the poorly-studied tocotrienol-rich vitamin E from palm oil Tocovid in DKD patients.

Tocotrienols have been shown to have significantly more potent antioxidant properties compared to tocopherol with superior antiglycaemic, anticholesterolaemic, anti-inflammatory, neuroprotective, and cardioprotective properties The failure of intervention trials contrasts with studies examining the influence of general dietary trends on renal function and emerging prospective evidence.

A recent systematic review into the effects of dietary interventions in CKD found evidence that some general dietary trends were associated with higher eGFR and reduced risk of ESRD and its associated risk factors Despite uncertainty around the precise mechanisms and nutrients associated with improved renal function and reduced mortality, increased circulating antioxidant levels have been proposed as a probable explanation Similarly, evidence from prospective studies suggest dietary carotenoids may provide a beneficial role, either as part of a multi-faceted lifestyle or independently, given albuminuria has been associated with diminished levels of carotenoid-intake A recently published study by Hirahatake et al.

investigated the relationship between dietary intake and renal function over five years Their study found that higher serum carotenoid levels were inversely associated with decline in kidney function. Our findings are consistent with this evidence and suggest the xanthophyll subclass significantly contribute to the beneficial effects of delaying CKD.

Their study also found no significant association for both tocopherol isoforms and lycopene, for which the existing cross-sectional evidence is conflicting. Overall, the current evidence for dietary antioxidant intervention in preventing or delaying renal dysfunction remains unclear.

Inadequately powered studies, intervention duration and heterogeneity in antioxidant dosage may contribute to the lack of consistency in the findings reported from supplement interventional trials.

Our findings suggest a potential future role for dietary carotenoids in early intervention - particularly those of the xanthophyll subclass. This highlights the need for an improved understanding of the exogenous antioxidant milieu in maintaining renal function to inform future interventions, particularly given the lack of cost-effective treatments for CKD.

However, further studies are required to confirm our findings and elucidate the true association between renal function and exogenous antioxidants to explore the potential role of these modifiable factors in delaying or preventing disease.

Foreman, K. et al. Forecasting life expectancy, years of life lost, all-cause and cause-specific mortality for causes of death: reference and alternative scenarios — for countries and territories.

Article PubMed PubMed Central Google Scholar. James, M. Early recognition and prevention of chronic kidney disease.

Article history Published Online:. Cite Icon Cite. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. We have no conflict of interest to declare. Walter MF, Jacob RF, Bjork RE, Jeffers B, Buch J, Mizuno Y, Mason RP: Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study.

J Am Coll Cardiol ; Shoji T, Fukumoto M, Kimoto E, Shinohara K, Emoto M, Tahara H, Koyama H, Ishimura E, Nakatani T, Miki T, Tsujimoto Y, Tabata T, Nishizawa Y: Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease.

Kidney Int ; Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE: A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.

Arch Intern Med ; Himmelfarb J, Ikizler TA, Ellis C, Wu P, Shintani A, Dalal S, Kaplan M, Chonchol M, Hakim RM: Provision of antioxidant therapy in hemodialysis PATH : a randomized clinical trial.

J Am Soc Nephrol ; Massy ZA, Stenvinkel P, Drueke TB: The role of oxidative stress in chronic kidney disease. Semin Dial ; Rebholz CM, Wu T, Hamm LL, Arora R, Khan IE, Liu Y, Chen CS, Mills KT, Rogers S, Kleinpeter MA, Simon EE, Chen J: The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study.

Am J Nephrol ; Galle J, Quaschning T, Seibold S, Wanner C: Endothelial dysfunction and inflammation: what is the link? Kidney Int Suppl ;SS Ilori TO, RO YS, Kong SY, Gutierrez RM, Ojo AO, Judd AE, Narayan KM, Goodman M, Plantinga L, McClellan W: Oxidative balance score and chronic kidney disease.

Goodman M, Bostick RM, Dash C, Flanders WD, Mandel JS: Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures. Ann Epidemiol ; Van Hoydonck PG, Temme EH, Schouten EG: A dietary oxidative balance score of vitamin C, beta-carotene and iron intakes and mortality risk in male smoking Belgians.

J Nutr ; Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication.

However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions.

Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor s.